Physician profile
Daniel Kueter
NPI 1184714180
$20,582.65
in general payments reported to CMS, 2019-2025
8 companies · $8,867 in 2025
The $8,867 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,708 · 2020: $1,770 · 2021: $2,188 · 2022: $1,642 · 2023: $1,346 · 2024: $62.60 · 2025: $8,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,400 · Travel and Lodging: $2,683 · Food and Beverage: $1,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,400.00 |
| Travel and Lodging | $2,683.29 |
| Food and Beverage | $1,191.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $8,709.81 | 2025 | Magnetos |
| Globus Medical, INC. | $7,928.28 | 2019-2022 | |
| Nuvasive, INC. | $2,286.58 | 2019 | |
| Centinel Spine, LLC | $1,345.80 | 2023 | Prodisc C Vivo |
| Depuy Synthes Sales INC. | $200.64 | 2024-2025 | Velys, Teligen, Conduit |
| Stryker Corporation | $76.73 | 2019 | |
| Abbott Laboratories | $18.79 | 2024 | Eterna |
| Ultragenyx Pharmaceutical INC. | $16.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Kueter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.